14Sep 2023
Laparoscopic adjustable gastric banding with liraglutide in adults with obesity and type 2 diabetes (GLIDE)

Laparoscopic adjustable gastric banding with liraglutide in adults with obesity and type 2 diabetes (GLIDE)

A pilot study, GLIDE, explored the effectiveness of Liraglutide combined with Laparoscopic Adjustable Gastric Banding (LAGB) in managing Type 2 Diabetes (T2DM) and obesity. The trial, conducted over 12 months, revealed no significant difference in glycemic control or weight loss between the Liraglutide and placebo groups at the 6-month and 12-month marks. The study suggests the need for larger trials to fully assess the potential benefits of GLP-1 agonists, especially weekly agents like semaglutide or tirzepatide, following metabolic surgery.

  • #endo-diabetology

Like

Save

Share